The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction - PubMed (original) (raw)
. 2012 Sep;32(9):2206-13.
doi: 10.1161/ATVBAHA.112.254409. Epub 2012 Jul 12.
Constance Auvynet, Lucie Poupel, José Vilar, Edouard Dumeau, Adèle Richart, Alice Récalde, Yasmine Zouggari, Kiave Yune Ho Wang Yin, Patrick Bruneval, Gilles Renault, Carmen Marchiol, Philippe Bonnin, Bernard Lévy, Raffaella Bonecchi, Massimo Locati, Christophe Combadière, Jean-Sébastien Silvestre
Affiliations
- PMID: 22796582
- DOI: 10.1161/ATVBAHA.112.254409
The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction
Clément Cochain et al. Arterioscler Thromb Vasc Biol. 2012 Sep.
Abstract
Objective: Leukocyte infiltration in ischemic areas is a hallmark of myocardial infarction, and overwhelming infiltration of innate immune cells has been shown to promote adverse remodeling and cardiac rupture. Recruitment of inflammatory cells in the ischemic heart depends highly on the family of CC-chemokines and their receptors. Here, we hypothesized that the chemokine decoy receptor D6, which specifically binds and scavenges inflammatory CC-chemokines, might limit inflammation and adverse cardiac remodeling after infarction.
Methods and results: D6 was expressed in human and murine infarcted myocardium. In a murine model of myocardial infarction, D6 deficiency led to increased chemokine (C-C motif) ligand 2 and chemokine (C-C motif) ligand 3 levels in the ischemic heart. D6-deficient (D6(-/-)) infarcts displayed increased infiltration of pathogenic neutrophils and Ly6Chi monocytes, associated with strong matrix metalloproteinase-9 and matrix metalloproteinase-2 activities in the ischemic heart. D6(-/-) mice were cardiac rupture prone after myocardial infarction, and functional analysis revealed that D6(-/-) hearts had features of adverse remodeling with left ventricle dilation and reduced ejection fraction. Bone marrow chimera experiments showed that leukocyte-borne D6 had no role in this setting, and that leukocyte-specific chemokine (C-C motif) receptor 2 deficiency rescued the adverse phenotype observed in D6(-/-) mice.
Conclusions: We show for the first time that the chemokine decoy receptor D6 limits CC-chemokine-dependent pathogenic inflammation and is required for adequate cardiac remodeling after myocardial infarction.
Similar articles
- Ly6Chigh Monocytes Oscillate in the Heart During Homeostasis and After Myocardial Infarction-Brief Report.
Schloss MJ, Hilby M, Nitz K, Guillamat Prats R, Ferraro B, Leoni G, Soehnlein O, Kessler T, He W, Luckow B, Horckmans M, Weber C, Duchene J, Steffens S. Schloss MJ, et al. Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1640-1645. doi: 10.1161/ATVBAHA.117.309259. Epub 2017 Jun 29. Arterioscler Thromb Vasc Biol. 2017. PMID: 28663258 - Splenic Ly6Chi monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice.
Tomczyk M, Kraszewska I, Szade K, Bukowska-Strakova K, Meloni M, Jozkowicz A, Dulak J, Jazwa A. Tomczyk M, et al. Basic Res Cardiol. 2017 Jul;112(4):39. doi: 10.1007/s00395-017-0629-y. Epub 2017 May 22. Basic Res Cardiol. 2017. PMID: 28534119 Free PMC article. - CD8+ T-cells negatively regulate inflammation post-myocardial infarction.
Ilatovskaya DV, Pitts C, Clayton J, Domondon M, Troncoso M, Pippin S, DeLeon-Pennell KY. Ilatovskaya DV, et al. Am J Physiol Heart Circ Physiol. 2019 Sep 1;317(3):H581-H596. doi: 10.1152/ajpheart.00112.2019. Epub 2019 Jul 19. Am J Physiol Heart Circ Physiol. 2019. PMID: 31322426 Free PMC article. - Chemokines in the ischemic myocardium: from inflammation to fibrosis.
Frangogiannis NG. Frangogiannis NG. Inflamm Res. 2004 Nov;53(11):585-95. doi: 10.1007/s00011-004-1298-5. Inflamm Res. 2004. PMID: 15693606 Review. - Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6.
Graham GJ, Locati M. Graham GJ, et al. J Pathol. 2013 Jan;229(2):168-75. doi: 10.1002/path.4123. J Pathol. 2013. PMID: 23125030 Review.
Cited by
- Macrophage heterogeneity in myocardial infarction: Evolution and implications for diverse therapeutic approaches.
Kanuri B, Sreejit G, Biswas P, Murphy AJ, Nagareddy PR. Kanuri B, et al. iScience. 2024 Jun 14;27(7):110274. doi: 10.1016/j.isci.2024.110274. eCollection 2024 Jul 19. iScience. 2024. PMID: 39040061 Free PMC article. Review. - The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
Xia W, Eltrich N, Vielhauer V. Xia W, et al. Front Immunol. 2024 May 10;15:1377913. doi: 10.3389/fimmu.2024.1377913. eCollection 2024. Front Immunol. 2024. PMID: 38799420 Free PMC article. - Regenerative loss in the animal kingdom as viewed from the mouse digit tip and heart.
Tan FH, Bronner ME. Tan FH, et al. Dev Biol. 2024 Mar;507:44-63. doi: 10.1016/j.ydbio.2023.12.008. Epub 2023 Dec 24. Dev Biol. 2024. PMID: 38145727 Review. - Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction.
Zuo W, Sun R, Ji Z, Ma G. Zuo W, et al. Cell Mol Biol Lett. 2023 Oct 19;28(1):81. doi: 10.1186/s11658-023-00491-4. Cell Mol Biol Lett. 2023. PMID: 37858035 Free PMC article. Review. - Fractalkine/CX3CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?
Jeyalan V, Austin D, Loh SX, Wangsaputra VK, Spyridopoulos I. Jeyalan V, et al. Cells. 2023 Sep 28;12(19):2377. doi: 10.3390/cells12192377. Cells. 2023. PMID: 37830591 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases